Name: Adjuvant Therapy of Breast Cancer (en Inglés)
Price: 354990.00 CLP
Availability: InStock
Author: Henderson, I. Craig
ISBN: 9781461365501

portada Adjuvant Therapy of Breast Cancer (en Inglés)

Formato

Libro Físico

Editorial

Springer

Autor

Henderson, I. Craig

Idioma

Inglés

N° páginas

464

Encuadernación

Tapa Blanda

Dimensiones

23.4 x 15.6 x 2.5 cm

Peso

0.67 kg.

ISBN13

9781461365501

Categorías

Quimioterapia
Hacer frente al cáncer

Adjuvant Therapy of Breast Cancer (en Inglés)

Henderson, I. Craig (Autor) · Springer · Tapa Blanda

Libro Nuevo

$ 354.990

$ 493.040

Ahorras: $ 138.050

28% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Lunes 05 de Agosto y el Jueves 15 de Agosto.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Adjuvant Therapy of Breast Cancer (en Inglés)"

The results of randomized trials evaluating the use of early or adjuvant systemic treatment for patients with resectable breast cancer provide an eloquent rebuttal to those who would argue that we have made no progress in the treatment of cancer. Many of the tumors that we have been most successful in curing with chemotherapy and other newer forms of treatment are relatively uncommon. In contrast, breast cancer continues to be the single most common malignancy among women in the western world, is increasingly a cause of death throughout Asia and Third-World countries, and remains one of the most substantial causes of cancer mortality world- wide. The use of mammography as a means of early detection has been shown to reduce breast cancer mortality by 25-35% among those popu- lations in which it is utilized. The use of adjuvant systemic treatment in appropriate patients provides a similar (and additional) reduction in breast cancer mortality. Few subjects have been so systematically studied in the history of medicine, and it seems fair to conclude that the value to adjuvant systemic therapy in prolonging the lives of women with breast cancer is more firmly supported by empirical evidence than even the more conventional or primary treatments using various combinations ofsurgery and radiotherapy.